The opposite view was a mainstream media narrative last year, in that a suggestion as such was very widely reported:
'The rapid waning of antibodies did not necessarily have implications for the efficacy of vaccine candidates currently in clinical trials, Imperial’s [Wendy] Barclay said.'
“A good vaccine may well be better than natural immunity,” she said.